Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 237-424-2 | CAS number: 13780-06-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Nitrites are essentially completely absorbed after oral exposure, with rapid removal from the circulation predominantly via conversion to nitrate and subsequent urinary excretion; calcium is also appreciably absorbed by this route. As such, an oral absorption figure of 100% is proposed for chemical safety assessment (CSA) and DNEL calculation for calcium nitrite.
Based on a high water solubility, any calcium nitrite reaching the lungs is likely to be absorbed. In line with ECHA guidance, a conservative default assumption of 100% inhalation absorption will be used for CSA and DNEL calculation (when extrapolating from an oral laboratory animal study to a human inhalation exposure).
The highly water-soluble nature of calcium nitrite is suggestive of a low potential for dermal uptake. As such a default value of 10% dermal absorption is proposed for CSA and DNEL calculation (when extrapolating from an oral laboratory animal study to a human dermal exposure).
Once absorbed, distribution and excretion are expected to be rapid, with little or no bioaccumulation anticipated.
Key value for chemical safety assessment
- Bioaccumulation potential:
- low bioaccumulation potential
- Absorption rate - oral (%):
- 100
- Absorption rate - dermal (%):
- 10
- Absorption rate - inhalation (%):
- 100
Additional information
No specific toxicokinetic studies on calcium nitrite are available. However, the nitrite ion in general has been well studied by Expert Groups [often in tandem with the related nitrate ion, since these species are known to interconvert] (EFSA, 2017a; Health Canada, 2013; IARC, 2010; OECD, 2005; WHO, 2011).
An EFSA Panel evaluation regarding the use of sodium and potassium nitrites as food additives considered that these cations “are expected to enter normal homeostatic processes, and are not expected to impact on the toxicity of the salts, which is determined by the nitrite ion; thus the properties of the cations are not discussed further” (EFSA, 2017a). As with the sodium and potassium cations, the calcium ion is ubiquitous in the human body and would therefore behave in a similar manner. As such, it is expected that EFSA would have had a similar conclusion on calcium nitrite if it had also considered it concurrently with the sodium and potassium nitrites. Given that the nitrite anion is clearly the toxicologically-active species in all of these salts, the current toxicokinetic assessment focuses on this species.
Absorption - nitrite
In humans, the systemic availability of (sodium) nitrite when given in solution is approximately 100% (EFSA, 2017a). Similarly, ingested nitrite (and nitrate) is “rapidly and almost completely absorbed” (Health Canada, 2013), though nitrite may react with gastric contents prior to absorption (WHO, 2011). In animals, nitrite is rapidly removed from the bloodstream or the intestinal tract by conversion to nitrate, likely due to “intestinal microflora activity”. Plasma nitrite concentrations peaked within 30 minutes of a single gavage dose in rats and mice (EFSA, 2017a).
No information is available on dermal absorption of nitrate or nitrite (Health Canada, 2013). Similarly, no data on the absorption of nitrites following inhalation were identified.
Absorption - calcium
Intestinal calcium is well-absorbed through both active [hormonally controlled], saturable, transcellular, and passive, non-saturable, paracellular processes (EFSA, 2017b). Absorption varies considerably throughout the human lifespan, being higher during periods of rapid growth (up to 60% during infancy) and lower in old age (EFSA, 2015).
Absorption – Key values for CSA
The available data suggest that oral absorption of nitrite is essentially complete, while calcium is also appreciably absorbed. Moreover, the relatively low molecular weight (MWt; ~132 g/mol) and, more critically, the high water solubility (>500 g/L; Sydney, 2018) are indicative of a high bioavailability of calcium nitrite, as ions, by the oral route. As such, predicted oral absorption of calcium nitrite is set at 100%.
As a highly water-soluble substance with a low MWt, ECHA (2017) guidance indicates that any calcium nitrite reaching the lungs is likely to be absorbed through aqueous pores. ECHA (2012) guidance notes “that if data on the starting route (oral) are available these should be used, but for the end route (inhalation), the worst-case inhalation absorption should still be assumed (i.e. 100%)”. Therefore, the health-precautionary figure of 100% as recommended by ECHA has been taken forward for the CSA, so as to result in the most health-precautionary DNEL.
Given the high water solubility of calcium nitrite, it is unlikely to be able to cross the lipid-rich environment of the stratum corneum to any great extent (i.e. dermal uptake is “low”) (ECHA, 2017). As such, the lower of the two ECHA (2017) default values for dermal absorption, 10%, would seem the more appropriate value for the current CSA.
Distribution/Metabolism - nitrite
Toxicokinetic studies in laboratory animals and humans demonstrated that sodium nitrite does not undergo first pass metabolism following oral exposure (EFSA, 2017a). Nitrite is converted to a variety of metabolites, predominantly nitrate via oxidation (EFSA, 2017a; WHO, 2011). Indeed, nitrite appears in a dynamic equilibrium with nitrate, with the latter being the normal state (Health Canada, 2013). In the blood, nitrite is highly reactive with [oxy]haemoglobin, resulting in the formation of methaemoglobin (associated with methaemoglobinaemia) (OECD, 2005), with concomitant production of nitrate (IARC, 2010). Nitric oxide and ammonia are minor nitrite metabolites (Health Canada, 2013).
Nitrite and nitrate are widely distributed in the body, with nitrate the predominant species (IARC, 2010). Parenteral administration of radiolabelled nitrite to mice and rabbits showed an even distribution throughout the soft tissues and organs within 5 minutes, mainly in the form of nitrate. In humans, the volume of distribution was larger than the body water, indicating that nitrites were distributed at higher concentrations in some tissues compared with the blood (EFSA, 2017a).
Nitrite has been shown to cross the placenta (possibly leading to foetal methaemoglobinaemia) in rodents (Health Canada, 2013; WHO, 2011).
Distribution/Metabolism - calcium
The total body burden of calcium in adults is in excess of 1 kg. Nearly all (99%) of total body calcium is located in the skeleton, the remaining 1% being equally distributed between the teeth and soft tissues, with only 0.1% in the extracellular fluid (WHO, 2004).
Calcium nitrite’s physico-chemical properties (low MWt and high water solubility) are supportive of an extensive distribution (of both calcium and nitrite ions).
Elimination (and Bioaccumulation) - nitrite
Nitrite is essentially completely converted to nitrate, which is subsequently excreted in the urine; faecal and urinary excretion of nitrite itself is negligible (EFSA, 2017a; WHO, 2011).
Nitrite is not normally detected in body tissues and fluids after oral administration. Elimination from the stomach occurs through two competing pathways: absorption, and reaction with amines [or other nitrosatable compounds] causing formation of nitroso compounds (Health Canada, 2013).
Accordingly, nitrite is considered to have only a low potential for bioaccumulation. This conclusion is supported by its highly water-soluble nature.
Elimination (and Bioaccumulation) - calcium
Unabsorbed dietary calcium is lost in the faeces. The main routes of obligatory (endogenous) calcium loss are urine, faeces, and skin and sweat (dermal losses) (EFSA, 2017b). Serum concentrations of calcium are homeostatically regulated to remain within a narrow range of 2.25–2.6 mmol/L (ionised calcium 1.1–1.4 mmol/L); concentrations of soft tissue calcium are maintained at the expense of bone (EFSA, 2015).
Conclusion
Experimental data on calcium and nitrite ions suggest that calcium nitrite would be well absorbed after oral exposure. Based on the limited available data, it is assumed that absorption following inhalation exposure could also be extensive. A low dermal bioavailability is anticipated.
Absorption values of 100%, 10% and 100% for the oral, dermal and inhalation routes, respectively, are proposed for the CSA, and considered health-precautionary for use in the calculation of DNEL values.
References (not including IUCLID ESRs):
ECHA (2012). European Chemicals Agency. Guidance on information requirements and chemical safety assessment. Chapter R.8: Characterisation of dose [concentration]-response for human health. Reference: ECHA-2010-G-19-EN. Version 2.1. November 2012.http://echa.europa.eu/documents/10162/13632/information_requirements_r8_en.pdf
ECHA (2017). European Chemicals Agency. Guidance on information requirements and chemical safety assessment. Chapter R.7c: endpoint specific guidance. Version 3.0. June 2017.https://echa.europa.eu/documents/10162/13632/information_requirements_r7c_en.pdf/e2e23a98-adb2-4573-b450-cc0dfa7988e5
EFSA (2015). European Food Safety Authority. Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific Opinion on Dietary Reference Values for calcium. EFSA Journal 2015;13(5):4101.https://efsa.onlinelibrary.wiley.com/doi/epdf/10.2903/j.efsa.2015.4101
EFSA (2017a). European Food Safety Authority. Panel on Food Additives and Nutrient Sources Added to Food. Re-evaluation of potassium nitrite (E 249) and sodium nitrite (E 250) as food additives. EFSA Journal 2017, 15(6), 4786.http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2017.4786/epdf
EFSA (2017b). European Food Safety Authority. Dietary Reference Values for nutrients. Summary report. EFSA Supporting publication 2017:e15121.http://onlinelibrary.wiley.com/doi/10.2903/sp.efsa.2017.e15121/epdf
Health Canada (2013). Guidelines for Canadian Drinking Water Quality: Guideline Technical Document – Nitrate and Nitrite. Catalogue No H144 -13/2-2013E-PDF.http://healthycanadians.gc.ca/publications/healthy-living-vie-saine/water-nitrate-nitrite-eau/alt/water-nitrate-nitrite-eau-eng.pdf?_ga=2.222634333.774105563.1517223052-337288668.1517223052
IARC (2010). International Agency for Research on Cancer. Ingested nitrate and nitrite and cyanobacterial peptide toxins. IARC Monographs on the Evaluation of Carcinogenic Risk to Humans. Volume 94, 14-21 June 2006.http://monographs.iarc.fr/ENG/Monographs/vol94/mono94.pdf
OECD (2005). Organization for Economic Co-operation and Development. SIDS Initial Assessment Report (SIAR) for SIAM 20. Sodium nitrite, CAS No: 7632-00-0.https://hpvchemicals.oecd.org/ui/handler.axd?id=5d2b8a51-1de5-4fc9-b7f1-09b3f8725ef5
WHO (2004). World Health Organization. Vitamin and mineral requirements in human nutrition. Second edition.http://apps.who.int/iris/bitstream/handle/10665/42716/9241546123.pdf
WHO (2011). World Health Organization. Nitrate and nitrite in drinking water. Background document for development of WHO guidelines for drinking-water quality. WHO/SDE/WSH/07.01/16/Rev/1.http://www.who.int/water_sanitation_health/dwq/chemicals/nitratenitrite2ndadd.pdf
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.